Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivasvan S Vykunta

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|May 19, 2024
Altered cancer metabolism and implications for next-generation CAR T-cell therapiesRishab Ramapriyan, Vivasvan S Vykunta, Gust Vandecandelaere, et al.
Science Immunology|March 1, 2024
Mast cells help organize the Peyer's patch niche for induction of IgA responsesMarco De Giovanni, Vivasvan S Vykunta, Adi Biram, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Molecular basis for potent B cell responses to antigen displayed on particles of viral sizeJeremy F Brooks, Julianne Riggs, James L Mueller, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2025
Submicron-Sampling of Living Cells by MacrophagesAmy C Fan, Rukman Thota, Nina Serwas, et al.
Nature|April 29, 2026
Submicrometre sampling of living cells by macrophagesAmy C Fan, Rukman R Thota, Nina Serwas, et al.
Nature Immunology|August 31, 2023
Molecular basis for potent B cell responses to antigen displayed on particles of viral sizeJeremy F Brooks, Julianne Riggs, James L Mueller, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Ultra-high efficiency T cell reprogramming at multiple loci with SEED-SelectionChristopher R Chang, Vivasvan S Vykunta, Daniel B Goodman, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Dynamic phosphatase-recruitment controls B-cell selection and oncogenic signalingJaewoong Lee, Mark E Robinson, Ruifeng Sun, et al.
Science Translational Medicine|November 9, 2022
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapiesDaniel B Goodman, Camillia S Azimi, Kendall Kearns, et al.
Nature Biomedical Engineering|May 5, 2023
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytesDana V Foss, Joseph J Muldoon, David N Nguyen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|May 19, 2024
Altered cancer metabolism and implications for next-generation CAR T-cell therapiesRishab Ramapriyan, Vivasvan S Vykunta, Gust Vandecandelaere, et al.
Science Immunology|March 1, 2024
Mast cells help organize the Peyer's patch niche for induction of IgA responsesMarco De Giovanni, Vivasvan S Vykunta, Adi Biram, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Molecular basis for potent B cell responses to antigen displayed on particles of viral sizeJeremy F Brooks, Julianne Riggs, James L Mueller, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2025
Submicron-Sampling of Living Cells by MacrophagesAmy C Fan, Rukman Thota, Nina Serwas, et al.
Nature|April 29, 2026
Submicrometre sampling of living cells by macrophagesAmy C Fan, Rukman R Thota, Nina Serwas, et al.
Nature Immunology|August 31, 2023
Molecular basis for potent B cell responses to antigen displayed on particles of viral sizeJeremy F Brooks, Julianne Riggs, James L Mueller, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Ultra-high efficiency T cell reprogramming at multiple loci with SEED-SelectionChristopher R Chang, Vivasvan S Vykunta, Daniel B Goodman, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Dynamic phosphatase-recruitment controls B-cell selection and oncogenic signalingJaewoong Lee, Mark E Robinson, Ruifeng Sun, et al.
Science Translational Medicine|November 9, 2022
Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapiesDaniel B Goodman, Camillia S Azimi, Kendall Kearns, et al.
Nature Biomedical Engineering|May 5, 2023
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytesDana V Foss, Joseph J Muldoon, David N Nguyen, et al.
Pageof 2